Interaction of cholesterol-conjugated alkylating oligonucleotide derivatives with cellular biopolymers  by Ryte, A.S. et al.
Volume 299, number 2, 124-126 FEBS 10797 
Q 1992 Federation of European Biochemical Societies 00145793~92~$5~~0 
March 1992 
Interaction of cholesterol-conjugated alkylating oligonucleotide 
derivatives with cellular biopolymers 
AS. Ryte, V.N. Karamyshev, M.V. Nechaeva, Z.V. Guskovn, E.M. Ivanova, V.F. Zarytova 
and V.V. Vlassov 
institute of Bioorgunic Cffemistry, Siberiatt Division of the USSR Academy of Sciences, Novosibirsk 630090, USSR 
Received 7 October 1991; revised version received 21 January 1991 
Interactions of oligonucleotide derivatives with mammalian cells and cellular biopolymers have been investigated. The derivatives were oligonu- 
cleotidcs bearing an alkylating 2-chloroethylamino group at the 3’-end and a cholesterol residue at the 5’-terminal phosphate. These compounds 
are readily taken up by cells and react +vith cellu!ar DNA, RNA and some proteins which may play a role in delivery or the compounds into cells. 
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1. INTRODUCTION 
It has been shown that conjugation of oligonu- 
cleotides to cholesterol dramatically improves their 
ability to enter animal cells and inhibit virus production 
[l-3]. Since conjugation of some other lipophilic groups 
[3,4] has proved to be much less efficient, the role of the 
cholesterol residue can not be explained simply by 
anchoring of the residue to the cell membrane due to its 
lipophilic nature and increase of the uptake of the com- 
pounds by the conventional endocytosis mechanism. It
seems that efficient transportation of the cholesterol- 
conjugated compounds is provided by some specific 
mechanism, probably the mechanism for the natural 
delivering of cholesterol to cells. We investigated inter- 
action of the cholesterol-conjugated alkylating oligonu- 
cleotide derivatives with cellular biopolymers, taking 
advantage of the possibility to accomplish affinity mo- 
dification of nucleic acids and proteins with this 
reagent, It was found that the derivatives alkylate cel- 
lular DNA and RNA which proves that the compounds 
are capable of entering cell nuclei as well as the cytosol. 
A few proteins capable of interacting with the deriva- 
tives were detected that may play a role in delivering the 
compounds into cells. 
2. MATERIALS AND METHODS 
Oligonuclcotides were synthesized by the phosphotricster method 
in solution [S,G]. The oligonucleotidcs were enzymat irally labelled with 
IzP, in some reagents he group CIRCHc was labelled witb ldC. Cou- 
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pling of the alkylating and cholesterol groups to oligonucleotidcs was 
accomplished as described earlier [7,8]. 
Asci tes carcinoma Krebs ? (KAC) cells and a cell line COS- 1 were 
treated with labelled oligonucleotide derivatives (in 0.5 PM) in 
DMEM serum free medium at 37OC, were washed and the oligonu- 
cleotide derivatives uptake was determined as described earlier [9.10]. 
Nuclear DNA, cgtoplasmic RNA and poly(A)+-mRNA were isolated 
as described elsewhere [l,ll]. Subcellular fractions of’ plasma 
membranes, endoplasmic reticulum, cytosol, and lysosomes were iso- 
lated and characterized by distribution of marker enzymes as de- 
scribed in [12]. The labelled proteins of the cells and cellular rractions 
were analyzed by SDS electrophorexis in g-158 gradient polyacrylm 
amide gels accord;ng to Laemmli [l3]. Grls were dried and autora- 
diographrd. 
3. RESULTS AND DISCUSSION 
To identify cellular biopolymers interacting with 
cholesterol-conjugated oligonucleotide derivatives, cells 
were treated with radiolabelled reagents: 
5’-[3zP]-CIRp(Tp),,ChS, CIR(pT),o, CIR(PT),~ 
[l”C]-ChS(pT)yrUCHRCl, where 
ChS = 
ClCH,CH, 
CIR = \ 
HsC 
,N 
ClRCH<= 
CiCH$H, , 
l-&C 
;” 
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Table I 
Incorporation of the 5’ “P~labclled alkylating oligonucleotidc deriva- 
tive RClp(Tp)&hs in different Krebs 2 ascite tumor cell fracticms 
_- 
Cell fraction Radioactivity in fractions 
cpmx IO-’ % 
Plasma membrane 126 7.1 
Nuclei 55s 31.3 
Cytosol 450 25.2 
Lysosomes 6 0.35 
Others 642 36.0 
These alkyla:ing derivatives can form covalent 
crosslinks with both nucleic acids and proteins [lo). 
Stability of the compounds in KAC cells and in culture 
medium was tested by gel electrophoresis [14]. Accord- 
ing to the electrophoretic lilobility data, the compounds 
were intact for at least 4 h and possessed the modifying 
groups. 
poly(A)+-mRNA and DNA with Chs(pT),rUCHRCl 
equaled 4.5 x lo-‘, 5.0 x 10ms and 3.5 x lo-’ mol of 
reagents per mol of nucleotides, respectively. 
The data on labelling of biopolyn;ers by 
ClRp(Tp),,ChS in different cellular fractions are sum- 
marized in Table I. It can be seen that the major part 
of the labelled biopolymers is located in the cell nucleus 
and in cytosol. A substantial amount of the label is 
associated with plasma membrane fractions, and only 
a small part of the labelled material is associated with 
lysosomes which suggests either fast degradation and 
release of the compounds from lysosomes or processing 
of the compounds in the cells, which does not involve 
lysosomes. 
Analysis of the radiolabclled proteins in whole cells 
and in different cellular fractions (Figs. 1 and 2) reveals 
a number of labelled peptides. The labelled peptide 
patterns are characteristic for each of the fractions in- 
vestigated. 
The KAC (5 x 10” cells/ml) cells were hcubated with 
the reagents for 2 h at 37°C and the cellular uptake of 
the compound and incorporation of the label in differ- 
ent cellular biopolymers were determined. Under the 
conditions used, approximately 1.3% of CIR(pT),, and 
25% of CRlp(Tp),,ChS or Chs(pT),rUCHRCl were 
taken up by the cells. Incorporation of the label oc- 
curred in both cellular RNA and DNA, which proves 
that the compounds can reach these nucleic acids in 
cytoplasm and nucleus. Under the above incubation 
conditions, the extent of modification of total RNA, 
Fig. 3 shows results of the analysis of the COS-1 cells 
proteins labelled by ClR(pT),(, and CIRp(Tp)&hS. It 
can be seen, that both derivatives react with the 80-kDa 
protein, identified earlier as putative nucleic acids bind- 
ing receptor [lo] and that the cholesterol-conjugated 
THPM LEE NC HW 
- 
- 
- 
- 
Fig. 1. SDS gradient (5-S%) PACE of isolated cell fractions, silver Fig. 2. Distribution of radioactivity among fractions of ascite car- 
staining. TH. total homogenate; ER, cndoplasmic reticulum; PM, cinoma cells a!kylatcd by [3zP]-CIRp(Tp),fhs SDS-PAGE. Cells 
plasma membrane; N. nuclei; C, cytosol; L, lyscsomes; MW, molccu- (5e10e per ml) were incubated with the oligonucleoridc derivntives (0.5 
lar wciSht markers. PM) for 2 h at 37’C in DMEM, washed and fractionated. 
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Fig. 3. Proteins of COS-I cells alkylated by CIR(pT),, and 
CIR(pT),,ChS, I, CIRp(Tp),,ChS + excess DNA; 2, CIRp(Tp),UChS 
+ excess oligonucleotidc; 3, CIRp(Tp),,ChS; 4, CIR(pT),,; 5, 
CIR(pT),, + excess oligonucleotide. 
derivative labels also a 250-kDa protein which is not 
detected in the experiment with ClR(pT),,. That the 
labelling is specific is proved by the fact, that an excess 
oligonucleotide or DNA in the cell culture prevents the 
proteins from labelling (Fig, 3, lanes 1 and 2). 
Results of these experiments suggest, hat cholesterol- 
conjugated oligonucleotide derivatives interact with a 
protein which apparently do not bind the parent oligo- 
nucleotides. A number of proteins were shown to inter- 
act with cholesterol. Thus a 14-kDa protein that binds 
cholesterol and is probably involved in cholesterol 
absorbtion in the brush border membrane was de- 
scribed [ 151. Recently spontaneous association of 
cholesterol conjugated oligonucleotides with LDL was 
reported [16], The protein detected in our experiments 
has a different molecular mass and it seems to be a 
different protein which may be either directly or in- 
directly involved in the efficient transportatiori of the 
compounds into cells. 
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